Establishing operational technology (OT) cybersecurity in pharmaceutical manufacturing is a journey. The risks are evident, doing nothing is not an option, and having a strategy to follow while also running current operations is essential to balance security and productivity.
Key findings of a new benchmarking study, conducted by Pharma Manufacturing in partnership with Dragos and Fortinet, reveal perceptions from pharma professionals on the status of their organization’s OT cybersecurity leadership, top pain points, current strategies, and investment goals. Download the report below to see how the pharma industry is progressing on its OT cybersecurity journey.
This content is sponsored by:
